With ever-expanding familial databases and collaboration, further biomarkers in PALB2 and CHEK2 familial breast cancers should be explored, with some small case series showing some benefit of platinum-based chemotherapy in these cancers [149]. This evidence concerns the gene PALB2 and breast carcinoma.